Streetbeat News

Equity Actions

VTVT

vTv Therapeutics Inc. (NASDAQ:VTVT) has sold all of its common stock in Reneo Pharmaceuticals for approximately $4.4 million. The proceeds will support vTv's preparations for the launch of the cadisegliatin Phase 3 program in type 1 diabetes. vTv remains eligible to receive up to $94.5 million in milestones, as well as royalties on potential sales of products under the Reneo license agreement.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:02 pm

F

GM

TSLA

Tesla CEO Elon Musk has acknowledged room for improvement in the company's deliveries despite its dominance in the EV market. This comes as other major players like General Motors and Ford Motor are scaling down their EV targets. Ford is delaying its $12 billion EV investment and will continue to focus on combustion engine and hybrid vehicles. General Motors has scrapped its plans to develop affordable EVs under $30K with Honda Motor and withdrew its EV production targets.

Portfolio Pulse from Anan Ashraf

November 01, 2023 | 11:36 am

NEPH

Nephros has appointed Judy Krandel as its new Chief Financial Officer (CFO), effective immediately.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:36 am

ALIT

Alight, Inc has updated its FY23 revenue forecast to $3.47B-$3.51B, representing a growth of 11% to 12%. The company also expects an adjusted EPS of $0.65-$0.69, up from the prior estimate of $0.62-$0.67. Other projections include adjusted EBITDA of $735M-$750M, BPaaS total contract value bookings of $700M-$900M, and an operating cash flow conversion rate of 45-55%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:34 am

TRMB

Trimble Inc. has announced that its CFO, David Barnes, will retire from the company in May 2024. Phil Sawarynski has been named as his successor.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:29 am

TRI

Thomson Reuters has announced plans to repurchase up to $1.0 billion of its shares under a new normal course issuer bid (NCIB). The company has received approval from the Toronto Stock Exchange for the renewal of its NCIB. Up to 10 million common shares, representing approximately 2.19% of the company’s issued and outstanding common shares, may be repurchased between November 3, 2023, and November 2, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:50 am

GOOS

Canada Goose has appointed Neil Bowden as its new CFO and Jonathan Sinclair as President of APAC. The changes in the executive team are expected to drive the company's growth strategy.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:46 am

IDXX

IDEXX Laboratories has updated its FY2023 guidance, raising its EPS outlook from $9.64-$9.90 to $9.74-$9.90, while lowering its sales guidance from $3.66B-$3.71B to $3.64B-$3.65B. The company's full year revenue growth outlook range is now 7.9% - 8.4% as reported and 8.3% - 8.8% organically. The overall reported revenue range was decreased by $20 million due to updated foreign exchange impact estimates. The company's operating margin outlook has been raised to 29.6% - 29.8%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:38 am

AVA

Avista Corp has revised its FY23 EPS guidance to $2.27-$2.37 from the previous $2.27-$2.47. The company's capital expenditures for the nine months ended Sept. 30, 2023, were $347 million, and it plans to spend $475 million for the year. Avista expects to increase its capital expenditures to $500 million in 2024, $525 million in 2025, and $550 million in 2026. It also plans to invest $15 million in 2023 in non-regulated investment opportunities and economic development projects.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:36 am

PRE

Prenetics Global has announced a reverse stock split of its outstanding ordinary shares at a ratio of 1-for-15.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:03 am